Has Lauren Warren received payments from drug or device companies?

Yes. Drug and device makers reported $1,901 in general payments to Lauren Warren across 97 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lauren Warren did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lauren Warren come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lauren Warren

Nurse Practitioner · Laurel, MDNPI 1023637923

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $969 and has fallen 96.1% since, to $38 in 2025.

$1,901in general payments, 2019–2025

Across 97 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$331
Sanofi-aventis U.S. LLC$244
W. L. Gore & Associates, Inc.$147
Dexcom, Inc.$144
Xeris Pharmaceuticals, Inc.$141
Novo Nordisk$113
plus $781 from 20 others

What the payments were for

Food & beverage$1,88799%
Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	23	$331
Sanofi-aventis U.S. LLC	12	$244
W. L. Gore & Associates, Inc.	2	$147
Dexcom, Inc.	8	$144
Xeris Pharmaceuticals, Inc.	7	$141
Novo Nordisk	6	$113
Lilly USA, LLC	4	$103
Amneal Pharmaceuticals LLC	5	$101
Novartis	4	$90
Boehringer Ingelheim	3	$52
Kowa Pharmaceuticals America, Inc.	3	$49
Zealand Pharma US, Inc.	3	$45
Mannkind Corporation	2	$41
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$38
Insulet Corporation	1	$29
AstraZeneca	2	$27
Abbott	1	$26
Recordati_rare_diseases_inc.	1	$23
EUSA Pharma (US) LLC	1	$23
Amarin Pharma, Inc.	1	$22
OPKO Pharmaceuticals, LLC	1	$21
Antares Pharma, Inc.	1	$21
Radius Health, Inc.	1	$19
AbbVie	1	$18
Amphastar Pharmaceuticals, Inc.	1	$17
Arbor Pharmaceuticals, Inc.	1	$15

How this compares

$1,901 in reported general payments places this provider in the 85th percentile of 1,562 nurse practitioner providers in Maryland.

See all nurse practitioner providers in Maryland →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	11	$196

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Laurel

Morgan GaleRockville$292K
Sherilyn BrinkleyBaltimore$100K
Michelle TurnerBaltimore$94K
Nelli ZafmanLutherville$67K
Ellen LancasterFallston$52K
Doris TateEaston$34K
Zeev NemirovskyBaltimore$19K
Martha ReilleyAnnapolis$18K
Stephanie ZwonitzerAnnapolis$16K
Jennifer MaglianoTimonium$16K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →